0
Your cart

Your cart is empty

Books > Medicine > General issues

Buy Now

Breast cancer treatment by targeting breast cancer stem cells (Paperback) Loot Price: R1,680
Discovery Miles 16 800
Breast cancer treatment by targeting breast cancer stem cells (Paperback): Phuc Van Pham

Breast cancer treatment by targeting breast cancer stem cells (Paperback)

Phuc Van Pham

 (sign in to rate)
Loot Price R1,680 Discovery Miles 16 800 | Repayment Terms: R157 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Donate to Against Period Poverty

This research focuses on gene therapy as well as immunotherapy to target the breast cancer stem cells in breast cancer treatment. Breast cancer stem cells were isolated and proliferated from malignant breast tumors. About gene therapy, we used knockdown gene therapy to suppress the CD44 expression. CD44 holds an important role in stemness maintenance of breast cancer stem cells. CD44 down regulation makes breast cancer stem cells sensitize to anti-tumor drug (doxorubicin). So that combinatorial therapy of CD44 down-regulation and doxorubicin strongly suppressed the tumor growth in NOD/SCID mice. In another way, we used dendritic cell therapy to target breast cancer stem cells. Dendritic cells were loaded with breast cancer stem cells derived antigens. The results also showed that dendritic cell vaccination inhibits the cancer development in mice models.

General

Imprint: Lap Lambert Academic Publishing
Country of origin: Germany
Release date: February 2012
First published: February 2012
Authors: Phuc Van Pham
Dimensions: 229 x 152 x 10mm (L x W x T)
Format: Paperback - Trade
Pages: 180
ISBN-13: 978-3-8473-4966-2
Categories: Books > Medicine > General issues > General
LSN: 3-8473-4966-X
Barcode: 9783847349662

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners